These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25806675)

  • 1. Use and Safety of Erythromycin and Metoclopramide in Hospitalized Infants.
    Ericson JE; Arnold C; Cheeseman J; Cho J; Kaneko S; Wilson E; Clark RH; Benjamin DK; Chu V; Smith PB; Hornik CP;
    J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):334-9. PubMed ID: 25806675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythromycin for feeding intolerance in preterm infants.
    Ng E; Shah V
    Cochrane Database Syst Rev; 2001; (2):CD001815. PubMed ID: 11406010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroesophageal reflux and prokinetic agents.
    Hammer D
    Neonatal Netw; 2005; 24(2):51-8; quiz 59-62. PubMed ID: 15835479
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythromycin for feeding intolerance in preterm infants.
    Ng E; Shah V
    Cochrane Database Syst Rev; 2000; (2):CD001815. PubMed ID: 10796273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prokinetic drug therapy in children: a review of current options.
    Chicella MF; Batres LA; Heesters MS; Dice JE
    Ann Pharmacother; 2005 Apr; 39(4):706-11. PubMed ID: 15755792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.
    Ng E; Shah VS
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001815. PubMed ID: 18646077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral erythromycin for treatment of feeding intolerance in preterm infants: a preliminary report.
    Sekteera W; Nuntnarumit P; Supapannachart S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1177-82. PubMed ID: 12549792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin versus metoclopramide for post-pyloric spiral nasoenteric tube placement: a randomized non-inferiority trial.
    Hu B; Ouyang X; Lei L; Sun C; Chi R; Guo J; Guo W; Zhang Y; Li Y; Huang D; Sun H; Nie Z; Yu J; Zhou Y; Wang H; Zhang J; Chen C
    Intensive Care Med; 2018 Dec; 44(12):2174-2182. PubMed ID: 30465070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC; So KW; Fung KS; Lee CH; Fok TF; Wong E; Wong W; Cheung KL; Cheng AF
    Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F177-82. PubMed ID: 11320044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants.
    ElHennawy AA; Sparks JW; Armentrout D; Huseby V; Berseth CL
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):281-6. PubMed ID: 12960650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness.
    Nguyen NQ; Chapman MJ; Fraser RJ; Bryant LK; Holloway RH
    Crit Care Med; 2007 Feb; 35(2):483-9. PubMed ID: 17205032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is metoclopramide safe for the premature infant?
    Eras Z; Oğuz SS; Dilmen U
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1655-7. PubMed ID: 23832734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroesophageal reflux medications in the treatment of apnea in premature infants.
    Kimball AL; Carlton DP
    J Pediatr; 2001 Mar; 138(3):355-60. PubMed ID: 11241042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prokinetic therapy for feed intolerance in critical illness: one drug or two?
    Nguyen NQ; Chapman M; Fraser RJ; Bryant LK; Burgstad C; Holloway RH
    Crit Care Med; 2007 Nov; 35(11):2561-7. PubMed ID: 17828038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic pyloric stenosis in mono-ovular extremely preterm twins after use of erythromycin.
    Shoji H; Suganuma H; Daigo M; Shinohara K; Umezaki H; Shiga S; Shimizu T; Yamashiro Y
    Pediatr Int; 2008 Oct; 50(5):701-2. PubMed ID: 19261125
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study.
    MacLaren R; Kuhl DA; Gervasio JM; Brown RO; Dickerson RN; Livingston TN; Swift K; Headley S; Kudsk KA; Lima JJ
    Crit Care Med; 2000 Feb; 28(2):438-44. PubMed ID: 10708180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin and feeding intolerance in premature infants: a randomized trial.
    Aly H; Abdel-Hady H; Khashaba M; El-Badry N
    J Perinatol; 2007 Jan; 27(1):39-43. PubMed ID: 17036029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants.
    Mansi Y; Abdelaziz N; Ezzeldin Z; Ibrahim R
    Neonatology; 2011; 100(3):290-4. PubMed ID: 21701222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intolerance.
    Nguyen NQ; Ching K; Fraser RJ; Chapman MJ; Holloway RH
    Intensive Care Med; 2008 Jan; 34(1):169-73. PubMed ID: 17701160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin as a prokinetic agent in newborns--useful or doubtful. Commentary on Y. Mansi et al.: Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants (Neonatology 2011;100:290-294).
    Ng PC
    Neonatology; 2011; 100(3):297-8. PubMed ID: 21701224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.